arbekacin has been researched along with trimethoprim, sulfamethoxazole drug combination in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koizumi, A; Konishi, M; Maeda, K; Masutani, T; Mikasa, K; Mori, K; Narita, N; Sano, R; Sawaki, M; Tsujimoto, M | 1 |
| Hijioka, S; Nakata, R; Nishimura, T; Sugita, K; Yoshinami, Y | 1 |
2 other study(ies) available for arbekacin and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
[An epidemiological investigation for MRSA and PRSP in Kinki area. Kinki Infection Working Group].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Haemophilus influenzae; Humans; Japan; Methicillin Resistance; Penicillin Resistance; Pseudomonas aeruginosa; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1998 |
[Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Drug Resistance, Bacterial; Hospitals, General; Japan; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Teicoplanin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |